多发性骨髓瘤合并动静脉血栓形成一例及文献复习_《华西医学》

作者：

王欣 ^1,2 , 黄杰 ¹ , 邓承祺 ¹ , 羊裔明 ¹ ,  牛挺 ¹

1四川大学华西医院血液科及血液学研究室（成都，610041）;2遂宁市中心医院血液科;

关键词：

多发性骨髓瘤合并症血栓形成诊断治疗

DOI：

CNKI: 51-1356/R.20120215.1036.001

视频：

导出 下载 收藏 扫码 引用

摘要 全文 图表 视频 参考文献 施引文献 补充材料

目的　提高对多发性骨髓瘤合并动静脉血栓形成的临床诊治水平。方法　报道1例表现为反复胸腔积液，同时合并反复、多处静脉和动脉血栓形成患者的临床资料，并复习文献。结果　该例62岁老年女性患者，合并右侧下肢静脉、肾动脉、脑动脉、颈动脉、肺动脉血栓反复形成，检查后明确诊断为多发性骨髓瘤IgG λ型、原发性淀粉样变，合并多处动静脉血栓形成，给予美法仑+泼尼松（MP）方案化疗和抗血小板、抗凝治疗后症状改善，随访13个月病情稳定，无新发血栓形成。结论　多发性骨髓瘤可能合并动静脉血栓形成等不典型表现，需要进一步提高认识。

引用本文： 王欣,黄杰,邓承祺,羊裔明,牛挺. 多发性骨髓瘤合并动静脉血栓形成一例及文献复习. 华西医学, 2012, 27(2): 179-181. doi: CNKI: 51-1356/R.20120215.1036.001 复制

1.	SwSwerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. 4th ed. Lyon: International agency for research on ca ncer (IARC) Press, 2008: 202.
2.	Kristinsson SY, Pfeiffer RM, Björkholm M, et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study[J]. Blood, 2010, 115(24): 4991-4998.
3.	魏晓娜, 檀金川. 以下肢动脉血栓为首发症状的多发性骨髓瘤1例[J]. 临床荟萃, 2010, 25(7): 619-620.
4.	刘增艳. 多发性骨髓瘤血栓形成及防治的研究进展[J]. 国际输血及血液学杂志, 2007, 30(6): 499-501.
5.	Auwerda JJ , Sonnevel d P , de-Maat MP, et al. Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma[J]. Haematologica, 2007, 92(2): 279-280.
6.	Ehce F, Fink L, Tricot G, et al. Acquired resistance to activated proteinC (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism[J]. Br J Haematol, 2006, 134(4): 399-405.
7.	Ying KJ, Zhou Y, Jiang H, et al. Multiple myeloma with pulmonary embolism: a case report[J]. Chin Med J (Engl), 2006, 119(17): 1481-1484.
8.	Uaprasert N, Voorhees PM, Mackman N, et al. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis[J]. Eur J Cancer, 2010, 46(10): 1790-1799.
9.	Barlogie B, Tricot G, Anaissie E, et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma[J]. N Engl J Med, 2006, 354(10): 1021-1030.
10.	Palumbo A, Cavo M, Bringhen S, et al. A prospective, randomized, phaseⅢ study of enoxaparin versus aspirin versus low-fixed-dose of warfarin in newly diagnosed myeloma patients treated with thalidomide containing regimens[J]. ASH Annual Meeting Abstracts, 2007, 110(11): 310.
11.	Richardson PG, Mitsiades C, Schlossman R, et al. Bortezomib in the front-line treatment of multiple myeloma[J]. Expert Rev Anticancer Ther, 2008, 8(7): 1054-1072.
12.	Kristinsson SY. Thrombosis in multiple myeloma[J]. Hematology, 2010, 2010(1): 437-444.

1. SwSwerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. 4th ed. Lyon: International agency for research on ca ncer (IARC) Press, 2008: 202.
2. Kristinsson SY, Pfeiffer RM, Björkholm M, et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study[J]. Blood, 2010, 115(24): 4991-4998.
3. 魏晓娜, 檀金川. 以下肢动脉血栓为首发症状的多发性骨髓瘤1例[J]. 临床荟萃, 2010, 25(7): 619-620.
4. 刘增艳. 多发性骨髓瘤血栓形成及防治的研究进展[J]. 国际输血及血液学杂志, 2007, 30(6): 499-501.
5. Auwerda JJ , Sonnevel d P , de-Maat MP, et al. Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma[J]. Haematologica, 2007, 92(2): 279-280.
6. Ehce F, Fink L, Tricot G, et al. Acquired resistance to activated proteinC (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism[J]. Br J Haematol, 2006, 134(4): 399-405.
7. Ying KJ, Zhou Y, Jiang H, et al. Multiple myeloma with pulmonary embolism: a case report[J]. Chin Med J (Engl), 2006, 119(17): 1481-1484.
8. Uaprasert N, Voorhees PM, Mackman N, et al. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis[J]. Eur J Cancer, 2010, 46(10): 1790-1799.
9. Barlogie B, Tricot G, Anaissie E, et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma[J]. N Engl J Med, 2006, 354(10): 1021-1030.
10. Palumbo A, Cavo M, Bringhen S, et al. A prospective, randomized, phaseⅢ study of enoxaparin versus aspirin versus low-fixed-dose of warfarin in newly diagnosed myeloma patients treated with thalidomide containing regimens[J]. ASH Annual Meeting Abstracts, 2007, 110(11): 310.
11. Richardson PG, Mitsiades C, Schlossman R, et al. Bortezomib in the front-line treatment of multiple myeloma[J]. Expert Rev Anticancer Ther, 2008, 8(7): 1054-1072.
12. Kristinsson SY. Thrombosis in multiple myeloma[J]. Hematology, 2010, 2010(1): 437-444.

上一篇
干扰素治疗多发性骨髓瘤疗效与安全性Meta分析
下一篇
以皮疹为突出表现的噬血细胞综合征一例

《华西医学》

多发性骨髓瘤合并动静脉血栓形成一例及文献复习

摘要 全文 图表 视频 参考文献 施引文献 补充材料

上一篇

下一篇

Format

Content

《华西医学》

多发性骨髓瘤合并动静脉血栓形成一例及文献复习

摘要 全文 图表 视频 参考文献 施引文献 补充材料

上一篇

下一篇

Format

Content

摘要全文图表视频参考文献施引文献补充材料